Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenib

BACKGROUND AND OBJECTIVE: It is unclear whether early morphological change (EMC) is a predictive marker for regorafenib in metastatic colorectal cancer (mCRC). Therefore, the present study investigated whether EMC can predict the outcome of mCRC patients receiving regorafenib. RESULTS: This study ev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Arai, Hiroyuki, Miyakawa, Kunihisa, Denda, Tadamichi, Mizukami, Takuro, Horie, Yoshiki, Izawa, Naoki, Hirakawa, Mami, Ogura, Takashi, Tsuda, Takashi, Sunakawa, Yu, Nakajima, Takako Eguchi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746401/
https://ncbi.nlm.nih.gov/pubmed/29299166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados